The high cost of patented drugs for rare diseases is posing a significant challenge to patients in India
with monopoly pricing leading to exorbitant treatment expenses. On World Rare Diseases Day
with monopoly pricing leading to exorbitant treatment expenses. On World Rare Diseases Day